awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35004750-11C358CA-EE8D-4DEE-8DF3-70F85F786461
Q35004750-11C358CA-EE8D-4DEE-8DF3-70F85F786461
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35004750-11C358CA-EE8D-4DEE-8DF3-70F85F786461
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points
P2860
Q35004750-11C358CA-EE8D-4DEE-8DF3-70F85F786461
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35004750-11C358CA-EE8D-4DEE-8DF3-70F85F786461
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36a33dbca2047164ea4474c5d2d11f76d46474df
P2860
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.